Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 7,000
- Avg volume
- 49,426
- Day's range
- $0.01 – $0.01
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAM...
Show more
Exousia Bio, Inc., a biotechnology company, designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026. The company was incorporated in 2022 and is based in Saint Petersburg, Florida.
- Industry
- Education & Training Services
- Sector
- Consumer Defensive
- Phone
- 509 605 6533
- Website
- https://exousiabio.com
- Address
- 7901 4th Street N, #23494, Saint Petersburg, United States
Latest news
No headlines yet.
Stocktwits
justFrog
Aug 6, 5:01 PM
$MAJI sounds like they are looking at distributing
$LMMY shares through a dividend with maji shares.
https://pbs.twimg.com/media/HPDPG9pXYAAyTRS?format=jpg&name=large
1 replies
WallStpolitician
Jul 10, 11:27 PM
$LMMY $MAJI
https://www.linkedin.com/posts/daby_glioblastoma-gbm-braincancer-activity-7481476101802938368-fqlG?utm_source=share&utm_medium=member_ios&rcm=ACoAAEQOoTwBdSR1-bP4ayBlkUKlCI_l4GzzQMo
🚀🚀🚀
0 replies
WallStpolitician
Jun 3, 1:20 AM
$MAJI $LMMY
https://moneychannelnyc.vids.io/videos/109adbb01a19e5c49a/roth-capital-conference-2026-michael-sheikh-ceo-nextel-medical
🚀📊💰
1 replies
griffinrc23
Dec 5, 12:52 PM
$LMMY Renowned Immunologist and Urological Surgeon Dr. Marvin Hausman Featured in New Exousia Bio, Inc. Interview
Drawing on over 50 years of drug development experience, Dr. Hausman strengthens the Company’s mission to combat cancer and other serious diseases.
For the full interview, please visit: https://lnkd.in/eYYsbmhc
0 replies
specul8r
Dec 4, 11:07 AM
$MAJI $LMMY
Great interview and DD info... lots of hints of big catalysts coming 👇👇👇👇👇
https://x.com/MicroCapTweets/status/1996386349889536191?t=L_mZ9I1DRVdx4qQJltZKJw&s=19
0 replies
griffinrc23
Dec 3, 1:34 PM
$LMMY LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc.
https://finance.yahoo.com/news/lamy-completes-strategic-acquisition-cancer-152800337.html
0 replies
